Hosted on MSN
Boehringer Ingelheim introduces LENZELTA®: A new vaccine advancing mastitis prevention in dairy cows
LENZELTA ® is a new vaccine significantly reducing the incidence and severity of clinical mastitis in vaccinated cows and heifers Boehringer Ingelheim has introduced LENZELTA®, a new vaccine designed ...
With colder months quickly approaching, the drive for a healthy herd is imminent. From raising healthy calves or protecting ...
A dairy cow can look healthy, produce milk that appears normal, and harbor an infection. The cause is often mastitis –– an ...
Researchers from the Universities of Otago and Auckland have teamed up with a leading New Zealand animal health innovator, Deosan, to develop new sanitisers for mastitis management. The development ...
Picture this scenario: You are a dairy farmer and have this healthy cow that is a super milk producer. The cow — whichever breed — produces so much milk you are the envy of fellow farmers in the ...
What happens in the dry period … doesn’t stay in the dry period. The productive revenue potential of an average U.S. Holstein is nearly $4,500. That value can be compromised when cows calve with ...
- Caused mostly by coliforms, including klebsiela, and strep non-ags. - Caused mostly by unclean conditions that expose teats to filth. - Infects cows mostly between milking times, but can also be ...
Boehringer Ingelheim introduces LENZELTA®: A new vaccine advancing mastitis prevention in dairy cows
LENZELTA® is a new vaccine significantly reducing the incidence and severity of clinical mastitis in vaccinated cows and heifers1. Administration is simple with two doses during the dry-off period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results